Nearly 200 representatives from China's pharmaceutical industry, academia and research institutes participated in the China Antibiotics Sixty Year Summit Forum held in Chengdu. The reporter learned from the meeting that Chinese pharmaceutical companies are “optimistic†about the development of Indian pharmaceutical manufacturing industry and strive to get started soon. From Chinese manufacturing to Chinese creation.
Shijin Group Co., Ltd. on behalf of Yue Jin mentioned in the "Rise and Future of China's Antibiotic Industry" that a report by Puhua Yongdao Zui shows that by 2020, Brazil, Russia, India, China (collectively known as BRIC) And the pharmaceutical markets of countries such as Indonesia, Mexico, and Turkey will account for one-fifth of the size of the global pharmaceutical market. India currently produces 8 percent of the world's pharmaceutical manufacturing and 25% of finished pharmaceuticals are exported to the international market. China is currently a major exporter of antibiotic raw materials such as penicillin. How to move from a big antibiotic country to a strong country, developing new drugs and playing the "China Creation" brand is the key.
Chen Bai, general manager of Guangzhou Baiyunshan Pharmaceutical Co., Ltd. believes that the hardware level of China's pharmaceutical industry has reached international requirements, and the current difficulties are in patents and the environment. From imitation to creation, this is the way China's pharmaceutical industry is practicing. After the financial crisis, the reason why the Chinese pharmaceutical industry did not enter the foreign market was mainly because it was not familiar with the foreign policy environment at that time and could not rush into the market. China's pharmaceutical industry has developed rapidly this year, and it is only a matter of time to move toward internationalization.
LYSO PET CT,Cardiac PET CT,LYSO Material CT,Full HD Lesion Detection
MinFound Medical Systems Co., Ltd , https://www.minfoundmed.com